0001819113-23-000071.txt : 20230815
0001819113-23-000071.hdr.sgml : 20230815
20230815162610
ACCESSION NUMBER: 0001819113-23-000071
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230812
FILED AS OF DATE: 20230815
DATE AS OF CHANGE: 20230815
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Zaranek Mike
CENTRAL INDEX KEY: 0001886590
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39727
FILM NUMBER: 231175219
MAIL ADDRESS:
STREET 1: C/O LIFESCI ACQUISITION II CORP.
STREET 2: 250 W 55TH STREET, #3401
CITY: NEW YORK
STATE: NY
ZIP: 10019
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Science 37 Holdings, Inc.
CENTRAL INDEX KEY: 0001819113
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
IRS NUMBER: 844278203
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 800 PARK OFFICES DRIVE
STREET 2: SUITE 3606
CITY: RESEARCH TRIANGLE PARK
STATE: NC
ZIP: 27709
BUSINESS PHONE: (984) 377-3737
MAIL ADDRESS:
STREET 1: 800 PARK OFFICES DRIVE
STREET 2: SUITE 3606
CITY: RESEARCH TRIANGLE PARK
STATE: NC
ZIP: 27709
FORMER COMPANY:
FORMER CONFORMED NAME: Lifesci Acquisition II Corp.
DATE OF NAME CHANGE: 20200723
4
1
wk-form4_1692131161.xml
FORM 4
X0508
4
2023-08-12
0
0001819113
Science 37 Holdings, Inc.
SNCE
0001886590
Zaranek Mike
800 PARK OFFICES DRIVE, SUITE 3606
RESEARCH TRIANGLE PARK
NC
27709
0
1
0
0
Chief Financial Officer
0
Common Stock
2023-08-12
4
M
0
256207
0
A
700490
D
Common Stock
2023-08-12
4
F
0
74813
0.44
D
625677
D
Restricted Stock Units
2023-08-12
4
M
0
256207
0
D
Common Stock
256207
512414
D
Acquisition of common stock resulting from vesting of the restricted stock units granted to Mr. Zaranek on August 12, 2022.
Disposition of common stock resulting from the withholding of securities for the payment of tax liability relating to the vesting of restricted stock units granted to Mr. Zaranek on August 12, 2022.
Each restricted stock unit represents a contingent right to receive one share of Science 37 Holdings, Inc.'s common stock.
On August 12, 2022, Mr. Zaranek received restricted stock units representing 768,621 shares subject to a three-year vesting schedule, vesting 33 1/3% on the first, second and third anniversaries of the grant date. As restricted stock units vest, the vested units are automatically converted to vested common stock on a one-for-one basis on the vesting date.
/s/ Christine Pellizzari, Attorney-in-Fact for Mike Zaranek
2023-08-15